New isothiazole derivatives. V. Antiinflammatory action of 3-methyl-5-benzoylaminoisothiazole-4-carboxy-para-ethoxyphenylamide.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001168:Arthritis / Q000188:drug therapy / Q000276:immunology; D001202:Ascitic Fluid / Q000032:analysis; D001549:Benzamides / Q000494:pharmacology; D005260:Female; D005549:Foreign-Body Reaction / Q000188:drug therapy; D005552:Forelimb; D005557:Formaldehyde; D005620:Freund's Adjuvant; D007249:Inflammation / Q000139:chemically induced / Q000188:drug therapy; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D010538:Peritonitis / Q000139:chemically induced / Q000188:drug therapy; D051381:Rats; D012701:Serotonin; D012995:Solubility; D013844:Thiazoles / Q000494:pharmacology* / Q000633:toxicity
D000893:Anti-Inflammatory Agents; D001549:Benzamides; D013844:Thiazoles; D005557:Formaldehyde; D012701:Serotonin; D005620:Freund's Adjuvant